2. Academic Validation
  3. Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase

Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase

  • J Med Chem. 2014 Jan 9;57(1):71-7. doi: 10.1021/jm401311d.
Linfeng Li 1,  Kun-Che Chang,  Yaming Zhou,  Biehuoy Shieh,  Jessica Ponder,  Adedoyin D Abraham,  Hadi Ali,  Anson Snow,  J Mark Petrash,  Daniel V LaBarbera
Affiliations

Affiliation

  • 1 Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Science, University of Colorado Anschutz Medical Campus , Aurora, Colorado 80045, United States.
PMID: 24341381 DOI: 10.1021/jm401311d
Abstract

β-Glucogallin (BGG), a major component of the Emblica officinalis medicinal plant, is a potent and selective inhibitor of Aldose Reductase (AKR1B1). New linkages (ether/triazole/amide) were introduced via high yielding, efficient syntheses to replace the labile ester, and an original two-step (90%) preparation of BGG was developed. Inhibition of AKR1B1was assessed in vitro and using transgenic lens organ cultures, which identified the amide linked glucoside (BGA) as a stable, potent, and selective therapeutic lead toward the treatment of diabetic eye disease.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z